Over the past decades, the approach to cardiomyopathies has deeply evolved. It has progressively transitioned from one predominantly based on clinical evaluation and conventional imaging towards an integrated and multidimensional approach that incorporates advanced imaging techniques, tissue characterization, and compr...
R. D. de Boer, A. Chaloupka, Bethan Cowley et al.· European Journal of Heart Fa...· 0 citations
- Cancer therapy-related cardiac dysfunction (CTRCD) limits optimal cancer therapy regimens. Although heart failure guideline-recommended medical therapy (GRMT) has been proposed as a cardioprotective strategy, robust evidence from randomized controlled trials (RCTs) remains insufficient due to limited study avai...
Y. Appels, R. Parvan, C. G. Mohan et al.· European Heart Journal, Supp...· 0 citations
BACKGROUND
Guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) is well established, but data on differences between men and women in real-world use, tolerability, and outcomes are limited. We examined these differences in contemporary HFrEF patients.
METHODS AND RESULTS...
M. I. Wilde, J. J. N. Krabbe, L. J. Bouhuijzen et al.· European Heart Journal - Qua...· 0 citations
– Emerging evidence has revealed that cardiovascular diseases (CVDs) identify individuals prone to developing cancer. However, the precise impact and which CVD is most associated with future cancer is not clear. Therefore, we present an up-to-date impact of CVD on cancer incidence and cancer-related mortality....
L. Yousif, P. Ameri, M. Vinci et al.· European Heart Journal, Supp...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.